These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 11533043

  • 1. beta-Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis.
    Claing A, Chen W, Miller WE, Vitale N, Moss J, Premont RT, Lefkowitz RJ.
    J Biol Chem; 2001 Nov 09; 276(45):42509-13. PubMed ID: 11533043
    [Abstract] [Full Text] [Related]

  • 2. The ADP ribosylation factor nucleotide exchange factor ARNO promotes beta-arrestin release necessary for luteinizing hormone/choriogonadotropin receptor desensitization.
    Mukherjee S, Gurevich VV, Jones JC, Casanova JE, Frank SR, Maizels ET, Bader MF, Kahn RA, Palczewski K, Aktories K, Hunzicker-Dunn M.
    Proc Natl Acad Sci U S A; 2000 May 23; 97(11):5901-6. PubMed ID: 10811902
    [Abstract] [Full Text] [Related]

  • 3. β-Arrestin-mediated Angiotensin II Signaling Controls the Activation of ARF6 Protein and Endocytosis in Migration of Vascular Smooth Muscle Cells.
    Charles R, Namkung Y, Cotton M, Laporte SA, Claing A.
    J Biol Chem; 2016 Feb 19; 291(8):3967-81. PubMed ID: 26703465
    [Abstract] [Full Text] [Related]

  • 4. Arf6 negatively controls the rapid recycling of the β2 adrenergic receptor.
    Macia E, Partisani M, Paleotti O, Luton F, Franco M.
    J Cell Sci; 2012 Sep 01; 125(Pt 17):4026-35. PubMed ID: 22611259
    [Abstract] [Full Text] [Related]

  • 5. The calcium-sensing receptor changes cell shape via a beta-arrestin-1 ARNO ARF6 ELMO protein network.
    Bouschet T, Martin S, Kanamarlapudi V, Mundell S, Henley JM.
    J Cell Sci; 2007 Aug 01; 120(Pt 15):2489-97. PubMed ID: 17623778
    [Abstract] [Full Text] [Related]

  • 6. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor.
    Goodman OB, Krupnick JG, Santini F, Gurevich VV, Penn RB, Gagnon AW, Keen JH, Benovic JL.
    Nature; 1996 Oct 03; 383(6599):447-50. PubMed ID: 8837779
    [Abstract] [Full Text] [Related]

  • 7. Unraveling G protein-coupled receptor endocytosis pathways using real-time monitoring of agonist-promoted interaction between beta-arrestins and AP-2.
    Hamdan FF, Rochdi MD, Breton B, Fessart D, Michaud DE, Charest PG, Laporte SA, Bouvier M.
    J Biol Chem; 2007 Oct 05; 282(40):29089-100. PubMed ID: 17675294
    [Abstract] [Full Text] [Related]

  • 8. Centaurin-alpha 1, an ADP-ribosylation factor 6 GTPase activating protein, inhibits beta 2-adrenoceptor internalization.
    Lawrence J, Mundell SJ, Yun H, Kelly E, Venkateswarlu K.
    Mol Pharmacol; 2005 Jun 05; 67(6):1822-8. PubMed ID: 15778454
    [Abstract] [Full Text] [Related]

  • 9. beta-Arrestin/AP-2 interaction in G protein-coupled receptor internalization: identification of a beta-arrestin binging site in beta 2-adaptin.
    Laporte SA, Miller WE, Kim KM, Caron MG.
    J Biol Chem; 2002 Mar 15; 277(11):9247-54. PubMed ID: 11777907
    [Abstract] [Full Text] [Related]

  • 10. ARF6 regulates angiotensin II type 1 receptor endocytosis by controlling the recruitment of AP-2 and clathrin.
    Poupart ME, Fessart D, Cotton M, Laporte SA, Claing A.
    Cell Signal; 2007 Nov 15; 19(11):2370-8. PubMed ID: 17719203
    [Abstract] [Full Text] [Related]

  • 11. Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex.
    Naga Prasad SV, Laporte SA, Chamberlain D, Caron MG, Barak L, Rockman HA.
    J Cell Biol; 2002 Aug 05; 158(3):563-75. PubMed ID: 12163475
    [Abstract] [Full Text] [Related]

  • 12. Methods to Investigate the β-Arrestin-Mediated Control of ARF6 Activation to Regulate Trafficking and Actin Cytoskeleton Remodeling.
    Charles R, Bourmoum M, Campbell S, Claing A.
    Methods Mol Biol; 2019 Aug 05; 1957():159-168. PubMed ID: 30919353
    [Abstract] [Full Text] [Related]

  • 13. The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic receptor into clathrin-coated pits.
    Laporte SA, Oakley RH, Holt JA, Barak LS, Caron MG.
    J Biol Chem; 2000 Jul 28; 275(30):23120-6. PubMed ID: 10770944
    [Abstract] [Full Text] [Related]

  • 14. G protein-coupled receptor endocytosis in ADP-ribosylation factor 6-depleted cells.
    Houndolo T, Boulay PL, Claing A.
    J Biol Chem; 2005 Feb 18; 280(7):5598-604. PubMed ID: 15590645
    [Abstract] [Full Text] [Related]

  • 15. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
    Anborgh PH, Seachrist JL, Dale LB, Ferguson SS.
    Mol Endocrinol; 2000 Dec 18; 14(12):2040-53. PubMed ID: 11117533
    [Abstract] [Full Text] [Related]

  • 16. Dynamin and beta-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization.
    Zhang J, Ferguson SS, Barak LS, Ménard L, Caron MG.
    J Biol Chem; 1996 Aug 02; 271(31):18302-5. PubMed ID: 8702465
    [Abstract] [Full Text] [Related]

  • 17. Role of arrestins in endocytosis and signaling of alpha2-adrenergic receptor subtypes.
    DeGraff JL, Gagnon AW, Benovic JL, Orsini MJ.
    J Biol Chem; 1999 Apr 16; 274(16):11253-9. PubMed ID: 10196213
    [Abstract] [Full Text] [Related]

  • 18. Beta-arrestin mediates desensitization and internalization but does not affect dephosphorylation of the thyrotropin-releasing hormone receptor.
    Jones BW, Hinkle PM.
    J Biol Chem; 2005 Nov 18; 280(46):38346-54. PubMed ID: 16183993
    [Abstract] [Full Text] [Related]

  • 19. Heterologous inhibition of G protein-coupled receptor endocytosis mediated by receptor-specific trafficking of beta-arrestins.
    Klein U, Müller C, Chu P, Birnbaumer M, von Zastrow M.
    J Biol Chem; 2001 May 18; 276(20):17442-7. PubMed ID: 11278476
    [Abstract] [Full Text] [Related]

  • 20. Characterization of dominant negative arrestins that inhibit beta2-adrenergic receptor internalization by distinct mechanisms.
    Orsini MJ, Benovic JL.
    J Biol Chem; 1998 Dec 18; 273(51):34616-22. PubMed ID: 9852134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.